Legal status · United States
Is Cerebrolysin legal in the United States?
No. Cerebrolysin is not an approved medicine in the United States; its classification is "Not approved". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. Human evidence: Moderate.
Cerebrolysin in the United States at a glance
| Classification | Not approved |
|---|---|
| FDA approval status | Not FDA-approved (approved in 30+ countries) |
| Evidence level | Moderate (research strength: Moderate) |
| Reviewed | Sep 2026 |
Classification and note come from the Cerebrolysin profile, checked against U.S. Food and Drug Administration (FDA) listings at the reviewed date.
What this means
- 01
No product containing Cerebrolysin is approved by FDA for any use in the United States, so nothing on the market is authorized for people.
- 02
"Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.
- 03
Importing, supplying or promoting it for human use can fall under medicines legislation in the United States. This page is general information, not legal advice.
What Cerebrolysin is
A standardized mixture of neuropeptides used clinically in many countries for stroke, dementia, and TBI.
Cerebrolysin is a preparation of low-molecular-weight neuropeptides and amino acids derived from porcine brain, used in more than 30 countries for decades for stroke, vascular dementia, Alzheimer's disease and traumatic brain injury. The controlled evidence is weaker than that history suggests.
Mechanism: Its neuropeptide fractions mimic neurotrophic factors such as BDNF and NGF and activate neuroprotective signaling pathways in the brain.
Regulatory history: Not FDA-approved (approved in 30+ countries)
How FDA treats this kind of product
Approves prescription drugs by indication and polices unapproved products, including peptides sold online. Compounding pharmacies may prepare some compounds under a prescription when the FDA places them on a permitted bulk-substances category.
The classification above is the The Longevity Archive reading of U.S. Food and Drug Administration listings for Cerebrolysin at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Cerebrolysin in other countries
Frequently asked questions
Is Cerebrolysin legal in the United States?
No. Cerebrolysin is not an approved medicine in the United States; its classification is "Not approved". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. Human evidence: Moderate.
Can I buy Cerebrolysin in the United States?
No approved product exists to buy. In the United States Cerebrolysin is classified as "Not approved", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.
Is Cerebrolysin FDA approved?
No. FDA status: Not FDA-approved (approved in 30+ countries). Current US classification: "Not approved". Evidence level: Moderate.
Related compounds in the United States
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Cerebrolysin live on its compound profile.
Cerebrolysin profileThis page is general information about the regulatory status of Cerebrolysin in the United States, current as of Sep 2026. It is not legal advice, and classifications change; check U.S. Food and Drug Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.